Nanomedicines promise fewer side effects in treating cancer

June 6, 2012

A new generation of cancer treatments based on nanotechnology is making its way out of the laboratory and into the clinic with the promise of targeting cancer cells while steering clear of healthy tissue, according to the current edition of Chemical & Engineering News (C&EN). C&EN is the weekly newsmagazine of the American Chemical Society (ACS).

In the cover story, C&EN Senior Editor Bethany Halford explains that today's anti-cancer medications impact healthy tissue in the process of killing . Patients thus may experience side effects, such as nausea and vomiting, that in some instances can be so severe that patients decline further treatment. New nanomedicine cancer treatments promise to focus on diseased tissue while leaving healthy parts of the body unscathed, reducing the severity of side effects.

The article explains how a new generation of nanoparticle-based medications bring anti-cancer drugs directly to the tumor. Because of their ultra-small size, particles of these drugs can slip through tiny passages in the blood vessels that nourish tumors, get inside tumors and even individual cancer cells, and do their work with precision. The article describes nanomedicines that already are in clinical trials with cancer patients and others that are moving in that direction.

Explore further: Taking aim at mysterious DNA structures in the battle against cancer

More information: Tiny Tech To Treat Cancer:

Related Stories

Nanotechnology in the Fight Against Cancer

February 5, 2010

A world-renowned medical researcher discusses the key role that nanotechnology has begun to play in the detection and treatment of cancer in an article that will appear in the March 2010 edition of Mechanical Engineering ...

Consumers' close encounters with nanoparticles

August 10, 2011

The most personal encounter that many consumers have had so far with the much-heralded field of nanotechnology is the topic of an article in the current edition of Chemical & Engineering News (C&EN), the American Chemical ...

Recommended for you

Moonlighting molecules: Finding new uses for old enzymes

November 27, 2015

A collaboration between the University of Cambridge and MedImmune, the global biologics research and development arm of AstraZeneca, has led researchers to identify a potentially significant new application for a well-known ...

A new form of real gold, almost as light as air

November 25, 2015

Researchers at ETH Zurich have created a new type of foam made of real gold. It is the lightest form ever produced of the precious metal: a thousand times lighter than its conventional form and yet it is nearly impossible ...

Getting under the skin of a medieval mystery

November 23, 2015

A simple PVC eraser has helped an international team of scientists led by bioarchaeologists at the University of York to resolve the mystery surrounding the tissue-thin parchment used by medieval scribes to produce the first ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.